The key protease responsible for the processing of the proglucagon peptide into GLP-1 is Psck1/3, which has shown to be upregulated in -cells during hyperglycaemic, hyperlipidemic, or inflammatory conditions to promote glucose-induced glucagon suppression, a compensatory response to a metabolic insult as in type 2 diabetes (205)
Efficacy and Safety of GPR119 Agonist DS-8500a in Japanese Patients with Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled, 12-Week Study
Even at microdoses, semaglutide improves insulin sensitivity for many patients
Other medications and health conditions If you take other medications especially those that affect blood sugar or weight or have existing health conditions, these can affect how your body responds to a GLP-1
We blend science with personalized care to craft a plan that fits your lifestyle and promotes your health